Citation: Md. Walker et al., A REVIEW OF QUALITY-OF-LIFE IN ALZHEIMERS-DISEASE PART 1 - ISSUES IN ASSESSING DISEASE IMPACT, PharmacoEconomics, 14(5), 1998, pp. 499-530
Citation: Aj. Sinclair et Aj. Bayer, CHRONIC DISEASE IN INSTITUTIONALIZED PATIENTS - BRITISH-GERIATRICS-SOCIETY HAS PRODUCED DOCUMENT ON DIABETES CARE, BMJ. British medical journal, 315(7121), 1997, pp. 1539-1539
Authors:
BAYER AJ
BOKONJIC R
BOOYA NH
DEMARIN V
ERSMARK B
FAIRBAIRN AF
FOLNEGOVICSMALC V
FREY H
TORRES MG
GUIRAUDCHAUMEIL B
HAUGAAR K
HENTSCHEL B
HEYNE S
HUGONOT L
HUGONOT R
JOVICIC J
KITTNER B
KNEZEVIC S
LANG C
LEVIC Z
POUSA SL
LOEB C
MALSCH U
GUIU JM
PARRA CM
VILALTA JM
PATHY MSJ
PATRIGNANI JH
ROSSNER M
ROUDIER M
RIEGER JS
SIITONEN O
TITLBACH O
WHALLEY LJ
WIKKELSO C
Citation: Aj. Bayer et al., EUROPEAN PENTOXIFYLLINE MULTIINFARCT DEMENTIA STUDY, European neurology, 36(5), 1996, pp. 315-321
Citation: Aj. Sinclair et al., PLASMA ANTIOXIDANT DEPLETION IN SUBJECTS WITH ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA, Journal of the American Geriatrics Society, 44(9), 1996, pp. 95-95
Citation: Mb. Liddell et al., NO EVIDENCE THAT COMMON ALLELIC VARIATION IN THE AMYLOID PRECURSOR PROTEIN (APP) GENE CONFERS SUSCEPTIBILITY TO ALZHEIMERS-DISEASE, Human molecular genetics, 4(5), 1995, pp. 853-858
Citation: Ja. Powell et al., SYMPTOMS OF COMMUNICATION BREAKDOWN IN DEMENTIA - CARERS PERCEPTIONS, European journal of disorders of communication, 30(1), 1995, pp. 65-75
Citation: S. Arino et Aj. Bayer, ELIGIBILITY OF ELDERLY PATIENTS WITH SUSPECTED MYOCARDIAL-INFARCTION FOR TREATMENT WITH STREPTOKINASE, Cardiology in the elderly, 2(5), 1994, pp. 415-420